Oral administration of tranilast to DCM animals (J2N-k, 4C30) reduced TRPV2 on the sarcolemma of their hearts, similar to the results observed after overexpressing the TRPV2 NT domain. Here, TRPV2 is linked to familial dilated cardiomyopathy.